- Home
- GBDC vs ACLX Comparison
GBDC vs ACLX Comparison
Compare GBDC & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBDC
- ACLX
- Stock Information
- Founded
- GBDC 2009
- ACLX 2015
- Country
- GBDC United States
- ACLX United States
- Employees
- GBDC N/A
- ACLX N/A
- Industry
- GBDC Finance: Consumer Services
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- GBDC Finance
- ACLX Health Care
- Exchange
- GBDC Nasdaq
- ACLX Nasdaq
- Market Cap
- GBDC 3.7B
- ACLX 4.4B
- IPO Year
- GBDC 2010
- ACLX 2022
- Fundamental
- Price
- GBDC $13.81
- ACLX $88.61
- Analyst Decision
- GBDC Buy
- ACLX Strong Buy
- Analyst Count
- GBDC 3
- ACLX 13
- Target Price
- GBDC $15.00
- ACLX $114.38
- AVG Volume (30 Days)
- GBDC 1.9M
- ACLX 475.1K
- Earning Date
- GBDC 11-18-2025
- ACLX 11-05-2025
- Dividend Yield
- GBDC 11.37%
- ACLX N/A
- EPS Growth
- GBDC N/A
- ACLX N/A
- EPS
- GBDC 1.41
- ACLX N/A
- Revenue
- GBDC $877,342,000.00
- ACLX $56,979,000.00
- Revenue This Year
- GBDC $23.63
- ACLX N/A
- Revenue Next Year
- GBDC N/A
- ACLX $220.95
- P/E Ratio
- GBDC $9.95
- ACLX N/A
- Revenue Growth
- GBDC 31.97
- ACLX N/A
- 52 Week Low
- GBDC $12.68
- ACLX $47.86
- 52 Week High
- GBDC $16.01
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- GBDC 44.87
- ACLX 57.31
- Support Level
- GBDC $13.74
- ACLX $84.00
- Resistance Level
- GBDC $14.17
- ACLX $92.34
- Average True Range (ATR)
- GBDC 0.20
- ACLX 3.61
- MACD
- GBDC 0.00
- ACLX -0.22
- Stochastic Oscillator
- GBDC 19.49
- ACLX 61.55
About GBDC Golub Capital BDC Inc.
Golub Capital BDC Inc is an externally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and capital appreciation by investing in senior secured and one-stop loans in United States middle-market companies. It also invests in the second lien and subordinated loans, warrants, and minority equity securities in United States middle-market companies. The company generally invests in securities that have been rated below investment grade by independent rating agencies or that would be rated below investment grade if rated. Maximum investment is done in USA and Canadian Companies, with maximum profit earned from those countries.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.